AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $457.34 million. The enterprise value is $434.11 million.
| Market Cap | 457.34M |
| Enterprise Value | 434.11M |
Important Dates
The last earnings date was Thursday, October 8, 2026, before market open.
| Earnings Date | Oct 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 42.05 million shares outstanding. The number of shares has increased by 1.84% in one year.
| Current Share Class | 42.05M |
| Shares Outstanding | 42.05M |
| Shares Change (YoY) | +1.84% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 10.19% |
| Owned by Institutions (%) | 79.31% |
| Float | 32.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| Forward PS | 1.31 |
| PB Ratio | 2.95 |
| P/TBV Ratio | 4.39 |
| P/FCF Ratio | 310.60 |
| P/OCF Ratio | 122.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 323.90, with an EV/FCF ratio of 294.51.
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | 323.90 |
| EV / EBIT | n/a |
| EV / FCF | 294.51 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.40 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 7.44 |
| Interest Coverage | -54.54 |
Financial Efficiency
Return on equity (ROE) is -19.21% and return on invested capital (ROIC) is -15.55%.
| Return on Equity (ROE) | -19.21% |
| Return on Assets (ROA) | -5.14% |
| Return on Invested Capital (ROIC) | -15.55% |
| Return on Capital Employed (ROCE) | -11.46% |
| Weighted Average Cost of Capital (WACC) | 5.85% |
| Revenue Per Employee | $514,839 |
| Profits Per Employee | -$52,114 |
| Employee Count | 632 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, AngioDynamics has paid $178,000 in taxes.
| Income Tax | 178,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.73% in the last 52 weeks. The beta is 0.30, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -1.73% |
| 50-Day Moving Average | 15.16 |
| 200-Day Moving Average | 12.46 |
| Relative Strength Index (RSI) | 18.42 |
| Average Volume (20 Days) | 889,156 |
Short Selling Information
The latest short interest is 1.29 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 1.29M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 3.98% |
| Short Ratio (days to cover) | 4.20 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $325.38 million and -$32.94 million in losses. Loss per share was -$0.79.
| Revenue | 325.38M |
| Gross Profit | 179.88M |
| Operating Income | -20.89M |
| Pretax Income | -32.76M |
| Net Income | -32.94M |
| EBITDA | 1.31M |
| EBIT | -20.89M |
| Loss Per Share | -$0.79 |
Balance Sheet
The company has $33.97 million in cash and $10.74 million in debt, with a net cash position of $23.23 million or $0.55 per share.
| Cash & Cash Equivalents | 33.97M |
| Total Debt | 10.74M |
| Net Cash | 23.23M |
| Net Cash Per Share | $0.55 |
| Equity (Book Value) | 163.96M |
| Book Value Per Share | 3.86 |
| Working Capital | 83.31M |
Cash Flow
In the last 12 months, operating cash flow was $3.67 million and capital expenditures -$2.23 million, giving a free cash flow of $1.44 million.
| Operating Cash Flow | 3.67M |
| Capital Expenditures | -2.23M |
| Depreciation & Amortization | 22.20M |
| Net Borrowing | -383,000 |
| Free Cash Flow | 1.44M |
| FCF Per Share | $0.03 |
Margins
Gross margin is 55.28%, with operating and profit margins of -6.42% and -10.12%.
| Gross Margin | 55.28% |
| Operating Margin | -6.42% |
| Pretax Margin | -10.07% |
| Profit Margin | -10.12% |
| EBITDA Margin | 0.40% |
| EBIT Margin | -6.42% |
| FCF Margin | 0.44% |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.84% |
| Shareholder Yield | -1.84% |
| Earnings Yield | -7.34% |
| FCF Yield | 0.32% |
Analyst Forecast
The average price target for AngioDynamics is $19.75, which is 81.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.75 |
| Price Target Difference | 81.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 5.45% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 2.55 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 6 |